1) N-terminal peptides
N-末端肽
1.
Peak pairs with a mass difference of 14 Da were identified as N-terminal peptides while the internal peptides were single peaks and the ratios of their peak intensity were calculated for relative quantification of proteins.
标记后的蛋白质的N端肽以相差14 Da的成对峰形式在质谱中出现,而非N-末端肽则是以单峰呈现,从而实现了末端肽的特异性识别;通过端肽的信号强度对3种标记蛋白质的不同比例的混合溶液实现了相对定量分析。
2) N-termini
N末端肽
3) amino-terminal fragment of the BNP
N末端脑尿钠肽
4) plasma N-terminal brain natriuretic peptide
N末端脑利钠肽
1.
Objective To evaluate the effect of percutaneous closure of patent ductus arteriosus(PDA)on left ventricular size and function by measuring plasma N-terminal brain natriuretic peptide(NT-proBNP)level and using two-dimensional echocardiography.
目的应用心脏超声技术及检测血浆N末端脑利钠肽(NT-proBNP)水平,探讨经皮动脉导管未闭(PDA)封堵术对心功能影响。
5) NTproBNP
N末端前脑钠肽
1.
Our study aims to observe the serum levels of patients with coronary heart disease(CHD) accompanied with congestive heart failure(CHF)and patients with CHD accompanied without CHF,to investigate relationships between the serum levels of adiponectin and NTproBNP and the role of serum adiponectin in patients with CHD accompanied with CHF.
方法收集连续入院的冠心病合并NYHAII-IV级患者60例和冠心病无心功能不全患者60例的血清和临床资料,选取性别与年龄与病例组相匹配对照组25例,测定空腹血清脂联素水平、N末端前脑钠肽(N-terminal portion of proBNP,NTproBNP)、hsCRP(high sensitivity C-Reactive Protein)及生化指标,比较各组间脂联素水平及与NTproBNP、hsCRP及生化指标的关系。
6) NT-proBNP
N末端脑钠肽
1.
Comparative study on BNP and NT-proBNP in the elderly with diastolic heart failure;
脑钠肽和N末端脑钠肽前体在老年舒张性心力衰竭患者中的比较
2.
Value of NT-proBNP in differential diagnosis of dyspnea which caused by heart disease or pulmonary disease;
N末端脑钠肽在鉴别心源性和肺源性呼吸困难中的应用研究
3.
Objective:To explore the relationship between plasma concentration of big endothelin-1(Big ET-1),N-teriminal probrain natriuretic peptide(NT-proBNP) and left ventricular aneurysm(LVA) after acute myocardial infarction(AMI).
目的:探讨急性心肌梗死(AMI)患者血浆大内皮素(ET)、N末端脑钠肽(NT-proBNP)水平和左室室壁瘤(LVA)形成之间的关系。
补充资料：二肽氨肽酶抑制剂
分子式：
CAS号：
性质：抑制二肽氨肽酶(EC3.4.14.1)活性的物质。二肽氨肽酶催化二肽(基)肽的水解，即作用于多肽的肽键水解后释放出二肽，故亦名二肽(基)转移酶。该酶参与血栓形成和止血的生化反应过程。该酶抑制剂如乙酰亮氨酸精氨醛等在临床上可用作抗血栓药或抗凝药。
CAS号：
性质：抑制二肽氨肽酶(EC3.4.14.1)活性的物质。二肽氨肽酶催化二肽(基)肽的水解，即作用于多肽的肽键水解后释放出二肽，故亦名二肽(基)转移酶。该酶参与血栓形成和止血的生化反应过程。该酶抑制剂如乙酰亮氨酸精氨醛等在临床上可用作抗血栓药或抗凝药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条